AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Sopov, V.
Right arrow Articles by Groshar, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sopov, V.
Right arrow Articles by Groshar, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.09.2949
AJR 2009; 193:W530-W539
© American Roentgen Ray Society


Pictorial Essay

The Metabolic Spectrum of Venous Thrombotic Disorders Found on PET/CT

Vladimir Sopov1, Hanna Bernstine1, Dorit Stern1,2, Nikolay Yefremov1, Jacob Sosna3,4 and David Groshar1,2

1 Department of Nuclear Medicine, Rabin Medical Center, Jabotinski St., Petah Tikva, 49100 Israel.
2 Department of Nuclear Medicine, Assuta Medical Center, Tel-Aviv, Israel.
3 Present address: Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
4 Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

OBJECTIVE. Thrombotic disorders detected on PET/CT are usually incidental findings and may change the treatment strategy and patient's disease prognosis. The purpose of this article is to present the spectrum of venous thrombotic disorders found on PET/CT.

CONCLUSION. The division of thrombotic disorders into metabolically nonactive and active thrombus may be helpful for differential diagnosis of underlying diseases causing thrombus formation. IV contrast media administration during PET/CT makes it possible to visualize the thrombus itself and helps to distinguish between benign and malignant metabolically active thrombus.

Keywords: FDG • PET/CT • venous thrombotic disorders


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Roentgen Ray Society.